Sean Melville

Sean Melville has a solid work experience in business development and analysis. Sean started their career in 2013 as a Microbiology Researcher and Lab Demonstrator at NUI Galway. Sean then worked as a Business Development Intern at Trinitas Ventures LTD from 2015 to 2016. In 2016, they joined Neurocentrx as a Business Development Analyst and stayed there until 2017. In 2018, they moved to Gatehouse Bio, where they initially served as a Business Development Analyst and later became the Head of Business Development. Currently, Sean works as a Senior Business Development Manager at Ardigen, starting in October 2022.

Sean Melville has a diverse education history. In 2021, they completed the HMX Fundamentals online certificate program at Harvard Medical School, focusing on immunology and various therapies for chronic inflammation. Sean studied subjects such as pharmacology essentials and immuno-oncology.

Prior to that, from 2015 to 2016, Sean pursued a Master of Science (MSc) degree at UCD Michael Smurfit Graduate Business School and School of Biomedical and Biomolecular Science. Sean achieved a first-class honors degree in Biotechnology and Business, with a GPA of 3.76 (1.1 scale).

Sean's undergraduate studies took place from 2010 to 2015 at the University of Galway. Sean earned a Bachelor of Science (B.Sc.) degree in Microbiology (level 8) and also studied Biochemistry (level 7). Sean'sperformance in these subjects earned him an upper second-class honors degree with a GPA of 3.55 (2.1 scale).

Before their university studies, Sean completed their Leaving Certificate at Gort Community School in Gort, Co Galway, between 2005 and 2010. The specific field of study at this level is not provided.

Overall, Sean Melville has a strong academic background, with expertise in biotechnology, business, immunology, microbiology, and biochemistry.